Strategy MSTR, the bitcoin-holding company, remains part of the Nasdaq 100 index after the annual reconstitution announced ...

Largest Exchange Transfer in History & Biggest IPO of the YearHighest Capital Raised Since 2021 - $46.65 Billion Raised NEW YORK, Dec. 18, ...

There’s something different about Walmart Inc. (NASDAQ: WMT) this holiday season, and it has nothing to do with the health of ...

"I am proud of Nasdaq’s unwavering commitment to powering resilient growth across the global economy. Over the course of the year, we made substantial progress on our vision to be the trusted fabric ...

The Nasdaq-100 index features the top growth stocks in the world, and tracking it has resulted in significant returns for long-term investors. Since the tariff pause back in April, both the Nasdaq and ...

TWFG Insurance Founder & CEO Richard “Gordy” Bunch III reflects on how it feels to be Nasdaq listed. TWFG Insurance is a high-growth, independent insurance distribution agency. We get up every day ...

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today unveiled a series of enhancements to its market surveillance platform, having completed a pilot which successfully ...

Helius Medical Technologies, Inc. announced that it has regained compliance with Nasdaq listing requirements, receiving confirmation from the Nasdaq Hearings Panel on July 7, 2025, that it meets the ...

As blockchain and similar technologies see increasing interest throughout the global financial system, Nasdaq is taking an important step to support the evolution of the markets. Recognizing the ...

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the ...

In today's video, I discuss recent updates affecting Apple (NASDAQ: AAPL) and what it means to its semiconductor partners. To learn more, check out the short video, consider subscribing, and click the ...

BOSTON and LONDON, July 29, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) ...